Reports

Drug name	NICE TAs	Comments
Decitabine injection	TA270 - Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)
Degarelix injection	TA404 - Degarelix for treating advanced hormone-dependent prostate cancer	Supported by ESCA
Denosumab injection (Prolia®)	TA204 - Denosumab for the prevention of osteoporotic fractures in postmenopausal women	ESCA
Denosumab injection (Xgeva®)	TA265 - Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours
Deucravacitinib	TA907 - Deucravacitinib for treating moderate to severe plaque psoriasis
Dexamethasone (Ozurdex®) 700mcg intravitreal implant	TA229 - Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion
Dexamfetamine tablets	TA98 - Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents	ESCAs and additional advice in relation to age of patient and CCG
Dexamfetamine tablets#Amber	TA98 - Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents	ESCAs and additional advice in relation to age of patient and CCG
Diltiazem cream (ANOHEAL)	Advice - Chronic anal fissure: 2% topical diltiazem hydrochloride	For patients unable to tolerate or with contraindications to GTN. Very expensive high relative cost.
Dimethyl fumarate	TA320 - Dimethyl fumarate for treating relapsing-remitting multiple sclerosis TA475 - Dimethyl fumarate for treating moderate to severe plaque psoriasis

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports